Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
180 participants
OBSERVATIONAL
2022-03-15
2022-10-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This community-based pilot will engage medical students, the local school district and the local health authority. The Educational program meets the requirements set by Centers for Disease Control and Prevention (CDC) in Guidelines for School Health Programs to Prevent Tobacco Use and Addiction. Following parental consent, the program will be implemented with all 7th and 8th grade students (children age 12-15 years) from the Elementary School in Tyniec Mały. This project is supported by the Head of Lower Silesian Oncology Center, the Head of Department of Oncology of Wroclaw Medical University, the Health and Social Affairs Department of City of Wroclaw and under the patronage of the Lower Silesia Governor's Office, the Polish Society of Oncology, the Polish Society of Public Health, the Lower Silesian Department of Polish Society of Cardiology and the European Association for Cancer Education (EACE).
Smoking Prevention Program is funded by the READS Grant Program from the American Association for Cancer Education (AACE).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of The Stanford Tobacco Prevention Toolkit
NCT04467034
Implementation of Smoking Cessation Within NCI Community Oncology Research Program (NCORP) Sites
NCT03291587
Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer
NCT01457469
To Explore the Factors Affecting the Effectiveness of Smoking Cessation
NCT03474783
Evaluating and Improving the Sustainability of State-level Tobacco Control Programs in the United States
NCT03598114
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
7th and 8th grade students (children age 12-15 years) from the elementary school
educational intervention
The program consists of five 50-minutes sessions conducted in person as scheduled during weekly class meetings. Educators will conduct workshops with PowerPoint presentations and worksheets dedicated to in-class activities.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
educational intervention
The program consists of five 50-minutes sessions conducted in person as scheduled during weekly class meetings. Educators will conduct workshops with PowerPoint presentations and worksheets dedicated to in-class activities.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 7th and 8th graders of the elementary school
* Parental consent
* Students consent
Exclusion Criteria
* Lack of students consent
12 Years
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford Reach Lab - Tobacco Prevention Toolkit
UNKNOWN
American Association for Cancer Education
UNKNOWN
Wroclaw Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Łukasz Moskal, MD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Łukasz Moskal, MD
Role: PRINCIPAL_INVESTIGATOR
Wroclaw Medical University
Konrad Reszka, MD
Role: PRINCIPAL_INVESTIGATOR
Wroclaw Medical University
Urszula Staszek-Szewczyk, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Wroclaw Regional Comprehensive Cancer Center, Department of Brachytherapy
Jagoda Łaba, MD
Role: PRINCIPAL_INVESTIGATOR
Wroclaw Medical University
Krzysztof Szewczyk, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Wroclaw Medical University, Department of Oncology, Division of Surgical Oncology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wroclaw Medical University
Wroclaw, Lower Silesian Voivodeship, Poland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Birge M, Duffy S, Miler JA, Hajek P. What Proportion of People Who Try One Cigarette Become Daily Smokers? A Meta-Analysis of Representative Surveys. Nicotine Tob Res. 2018 Nov 15;20(12):1427-1433. doi: 10.1093/ntr/ntx243.
Kaleta D, Polanska K, Rzeznicki A, Stelmach W, Wojtysiak P. Tobacco use patterns, knowledge, attitudes towards tobacco and availability of tobacco control training among school personnel from a rural area in Poland. Tob Induc Dis. 2017 Jan 11;15:3. doi: 10.1186/s12971-016-0110-y. eCollection 2017.
Related Links
Access external resources that provide additional context or updates about the study.
World Health Organization. Regional Office for Europe. 2020. Summary results of the global youth tobacco survey in selected countries of the WHO European Region. World Health Organization. Regional Office for Europe.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Smoking Prevention
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.